Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Postpartum Depression Market Expected To Become By 2029 Compared With Its 2025 Level?
The postpartum depression market has experienced substantial growth in recent years. Its value is projected to climb from $12.15 billion in 2024 to $16.05 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 32.1%. This expansion in the past can be linked to greater maternal mental health awareness, progress in research, various public health programs, and an increase in screening procedures.
The postpartum depression market is anticipated to experience substantial growth in the upcoming years. It is projected to reach $49.49 billion by 2029, with a compound annual growth rate (CAGR) of 32.5%. This expansion during the forecast period is driven by factors such as telehealth services, pharmacological advancements, maternal mental health legislation, and the expansion of the mental health workforce. Prominent trends for this period include integrated care models, peer support programs, perinatal mental health apps, and mental health screening tools.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp
What Are The Top Growth Drivers Impacting The Postpartum Depression Market Outlook?
The postpartum depression market is anticipated to expand due to an expected increase in postpartum depression cases. Postpartum depression is characterized by exaggerated worry that develops after giving birth, and it may also involve physical symptoms. Postnatal depression and postpartum anxiety frequently coexist, with symptoms potentially starting at any time within the first year after childbirth. The market’s growth is further driven by common treatments for postpartum depression, such as psychotherapy (also known as talk therapy or mental health counselling), medication, or a combination of both. For example, a survey of 1.1 million mothers conducted in February 2022 by the US-based University of Virginia School of Medicine (UVA SoM) revealed that first-time mothers, those under 25, and mothers of twins have the highest risk of postpartum depression. Among age groups, women aged 18-24 reported the highest rate of postpartum depression symptoms at 10%. Mothers of twins also reported higher rates, with 11.3% showing symptoms, compared to 8.3% of mothers with single children. Consequently, an increase in postpartum depression cases will propel the postpartum depression market.
What Are The Segment Types Shaping The Postpartum Depression Market?
The postpartum depressionmarket covered in this report is segmented –
1) By Types: Postpartum Blues; Postpartum Anxiety; Postpartum Obsessive Compulsive Disorder; Postpartum Panic Disorder; Postpartum Post-Traumatic Stress Disorder; Postpartum Psychosis; Other Types
2) By Treatment: Psychotherapy; Medication; Supplements; Other Treatments
3) By Route of Administration: Oral; Parenteral; Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Postpartum Blues: Mild Emotional Disturbances; Short-term Mood Swings
2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD); Panic Attacks
3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts; Compulsive Behaviors
4) By Postpartum Panic Disorder: Sudden Panic Attacks; Physical Symptoms
5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth; Flashbacks And Anxiety
6) By Postpartum Psychosis: Hallucinations; Severe Mood Swings
7) By Other Types: Mixed Mood Disorders; Comorbid Conditions With Postpartum
How Are Emerging Market Trends Shaping The Postpartum Depression Industry Landscape?
Companies operating within the postpartum depression market are actively pursuing new product innovations to sustain their competitive position. The limited available treatment choices have intensified the need for advancements in faster-acting therapies and creative approaches to care delivery for postpartum depression. For instance, in February 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics Inc., a US-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) accepted the filing of a new drug application (NDA) for zuranolone, intended for managing major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an experimental medication being investigated as a 14-day, once-daily, rapid-acting oral therapy for individuals with MDD and PPD. As a neuroactive steroid, zuranolone acts as a positive allosteric modulator of GABA-A receptors, which constitutes a unique method of action. It is believed to work in persons with depression by quickly resetting dysregulated neural networks to help restore brain function. Zuranolone impacts brain networks that govern mood, arousal, behavior, and even cognition.
Who Are The Top Performing Companies In The Postpartum Depression Market In Recent Years?
Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report
Which Regional Markets Are Contributing Most To The Postpartum Depression Industry Expansion?
North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Postpartum Depression Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp
Browse Through More Reports Similar to the Global Postpartum Depression Market 2025, By The Business Research Company
Mental Health Apps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report
Behavioral And Mental Health Software Global Market Report 2025
Residential Substance Abuse And Mental Health Facilities Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model